Commercial sector

Opioid Antagonists and Overdose Reversal Therapeutics

Companies developing or manufacturing reversal agents for ultrapotent synthetic opioids (fentanyl analogues, carfentanil) and incapacitating agents, including high-dose and long-acting opioid antagonists (naloxone, nalmefene), opioid-sequestering antibodies, and respiratory stimulants for opioid-induced respiratory depression.

Companies7
Commercial products14
Technology classes2
Countries1
Patents175

Profiled companies

Products
  • Emergent BioSolutions logo
    Emergent BioSolutions
    United States2
  • Cessation Therapeutics logo
    Cessation Therapeutics
    United States–
  • Elysium Therapeutics logo
    Elysium Therapeutics
    United States5
  • TMT-Rx (Torralva Medical Therapeutics) logo
    TMT-Rx (Torralva Medical Therapeutics)
    United States1
  • ARMR Sciences, Inc. logo
    ARMR Sciences, Inc.
    United States1
  • Clear Scientific, Inc. logo
    Clear Scientific, Inc.
    United States–

+ 1 more

← Back to what’s inside this report